Trevena to Participate in Upcoming Conferences in September 2019
September 03 2019 - 7:00AM
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical
company focused on the development and commercialization of novel
medicines for patients with Central Nervous System (CNS)
conditions, today announced that its management team will
participate in two upcoming conferences:
- H.C. Wainwright 21st Annual Global Investment Conference,
sponsored by H.C. Wainwright, to be held at the Lotte New York
Palace Hotel in New York City on Tuesday, September 10, 2019 at
9:35am ET. Live audio webcast and archived replay of the
presentation will be available on Trevena’s investor relations
website at https://investors.trevena.com/. Following the conclusion
of the presentation, the webcast will be available for replay for
30 days.
- Oppenheimer Fall Summit Focused on Specialty Pharma & Rare
Disease Companies, sponsored by Oppenheimer & Co., to be held
at the Parker New York Hotel in New York City on Wednesday,
September 23 and Thursday, September 24, 2019.
For more information about the conferences, or to
schedule a one-on-one meeting with Trevena’s management, please
contact KCSA Strategic Communications at Trevena@kcsa.com, or send
an email to lk@hcwco.com (H.C. Wainright), or
meghan.connor@opco.com (Oppenheimer & Co.).
About TrevenaTrevena, Inc.
is a biopharmaceutical company focused on the development and
commercialization of novel medicines for patients with Central
Nervous System conditions. The Company has four novel and
differentiated investigational drug candidates, including IV
oliceridine, for the management of moderate to severe acute pain in
hospitals, TRV250 for the acute treatment of migraine, and TRV734
for maintenance treatment of opioid use disorder. The Company has
also identified TRV045, a novel S1P receptor modulator that may
offer a new, non-opioid approach to managing chronic pain.
For more information, please
contact:
Investor Contact:Valter Pinto /
Allison SossKCSA Strategic CommunicationsPhone: 212-896-1254 /
212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and
Chief Business OfficerTrevena, Inc.Phone: 610-354-8840
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Sep 2023 to Sep 2024